AACR Annual Meeting 2014 | April 5-9th | San Diego, CA | Booth #2049
KeraFAST will be joining the oncology community at AACR 2014!
Our team of scientists invites you to visit our booth (#2049) to learn how we support researchers like you across the world by providing “Reagents for the Greater Good.”
Curious to know what cancer-specific reagents we offer for your research? Check out some of our many popular cancer research tools below or view more here.
Our research materials are not produced by KeraFAST, but instead are provided to you by your colleagues who participate in our The Investigator's Annexe program.
We believe providing scientists are "good guys" because they help accelerate scientific discoveries by making their research reagents available to the global research community. We also feel scientists purchasing these research reagents through us are "good guys" because they support future research by paying back to providing scientists and institutions through our generous profit sharing program.
Since all the "good guys" in the old Western movies wore white hats, we will be giving away white cowboy hats at AACR to researchers who believe in and support our “fair commerce” mission.
Are you white hat worthy? Come see us at booth 2049.
Popular Cancer Research Tools
Metastatic Histiocytoma Cell Lines
Induce systemic metastasis and study potential therapies in vivo.
Contributed by Thomas N. Seyfried, Ph.D., Boston College
MUC1 Antibodies
Identify MUC1 expression in various human cancer cells, such as carcinomas and sarcomas.
Contributed by Donald W. Kufe, M.D., Dana-Farber Cancer Institute
Photoreactive HDAC Inhibitors
Inhibit HDAC activity and study protein-ligand interactions, identify drug candidates, and map target binding sites.
Contributed by Pavel A. Petukhov, Ph.D., University of Illinois at Chicago
STAT3 Dominant Negative Lentivirus
Inhibit STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity to study oncogenesis.
Contributed by Lawrence Pfeffer, Ph.D., University of Tennessee
Quinol 2 Thioredoxin Reductase Inhibitor
Inhibit thioredoxin reductase to study in vitro cancerous proliferation and monitor in vivo tumor activity.
Contributed by Cancer Research Technology
Your Reagent
Do you have an oncology reagent from your laboratory to offer your colleagues?
Contributed by your Laboratory, your Institution
